S137 Short-acting and long-acting β2-agonists upregulate asthma-relevant pro-inflammatory mediators in human airway epithelial cells while short-acting muscarinic antagonists do not
Sign Up to like & getrecommendations! Published in 2019 at "Thorax"
DOI: 10.1136/thorax-2019-btsabstracts2019.143
Abstract: Introduction and objectives Despite their undoubted benefits, increased mortality is associated with overuse of short-acting β2-agonists (SABAs) and with using long-acting β2-agonists (LABAs) in the absence of inhaled corticosteroids (ICS). Mechanisms underlying these adverse effects… read more here.
Keywords: asthma relevant; short acting; epithelial cells; significant induction ... See more keywords